SEC Form D · filed February 11, 2022
Ventus Therapeutics U.S., Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Steven James · Walthum, MADirectorBrendan Bulik-Sullivan · Walthum, MADirectorZachary Mcnealy · Walthum, MAExecMichael Crackower · Waltham, MAExecJosh Resnick · Walthum, MADirectorDaniel Koerwer · Walthum, MAExecMarcelo Bigal · Walthum, MAExec · DirectorJerel Davis · Walthum, MADirectorMarkus Warmuth · c/o Ventus Therapeutics U.S.,, MADirectorMartin Schmid · Stare Hradiste, 2NDirectorMilton R. Berlinski · New York, NYExecAndrej Kiska · Luxembourg-Findel, LuxembourgDirectorRudolf Kadlec · Zvole u Prahy, 2NDirectorJon Frojen · New York, NYExec · DirectorJamie Price · New York, NYExecMatej Moravcik · Selce, 2BExecValerie Brown · New York, NYDirectorJane Pritchett Henderson · Walthum, MADirectorDolca Thomas · Walthum, MADirectorJohn Cassidy · Lexington, MADirectorGunnar K. Gunnarsson · Wayne, PAExecJack K. Eadie · Wayne, PADirectorVladimir K. Tamarkin · Wayne, PADirectorCharlie K. Wuischpard · Wayne, PADirectorMatthew Snyder · ARMONK, NYDirectorNicholas C. Stacey · Denver, COExecIvana Faltysova · Grand Cayman, Cayman IslandsExecKevin Phillip · Grand Cayman, Cayman IslandsExec · DirectorMarkus Warmuth · c/o Ventus Therapeutics U.S.,, MADirectorJane Pritchett Henderson · Walthum, MADirectorDolca Thomas · Walthum, MADirectorJohn Cassidy · Walthum, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗